Park West Asset Management LLC - Aug 27, 2021 Form 4 Insider Report for Kindred Biosciences, Inc. (KIN)

Role: 10%+ Owner
Signature: /s/ Grace Jimenez, Chief Financial Officer of Park West Asset Management LLC
Stock symbol: KIN
Transactions as of: Aug 27, 2021
Transactions value $: $0
Form type: 4
Date filed: 9/13/2021, 04:30 PM
Previous filing: Aug 17, 2021
Next filing: Feb 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KIN	Common Stock, par value $0.0001 per share	Other		-6M	-100%		0	Aug 27, 2021	See Footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Park West Asset Management LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	On August 27, 2021, pursuant to an Agreement and Plan of Merger, dated as of June 15, 2021, by and among Kindred Biosciences, Inc. (the "Company"), Elanco Animal Health Incorporated ("Elanco") and Knight Merger Sub, Inc., a wholly owned subsidiary of Elanco ("Merger Sub"), Merger Sub merged with and into the Company with the Company surviving as the wholly owned subsidiary of Elanco (the "Merger"). Immediately prior to the effective time of the Merger, each share of common stock, par value $0.0001 per share, of the Company was cancelled and automatically converted into the right to receive $9.25 per share in cash.
F2	Park West Asset Management LLC (the "Reporting Person") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company ("PWIMF"), and Park West Partners International, Limited, a Cayman Islands exempted company ("PWPI"). Peter S. Park ("Mr. Park"), through one or more affiliated entities, is the controlling manager of the Reporting Person.

Content

On August 27, 2021, pursuant to an Agreement and Plan of Merger, dated as of June 15, 2021, by and among Kindred Biosciences, Inc. (the "Company"), Elanco Animal Health Incorporated ("Elanco") and Knight Merger Sub, Inc., a wholly owned subsidiary of Elanco ("Merger Sub"), Merger Sub merged with and into the Company with the Company surviving as the wholly owned subsidiary of Elanco (the "Merger"). Immediately prior to the effective time of the Merger, each share of common stock, par value $0.0001 per share, of the Company was cancelled and automatically converted into the right to receive $9.25 per share in cash.

Park West Asset Management LLC (the "Reporting Person") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company ("PWIMF"), and Park West Partners International, Limited, a Cayman Islands exempted company ("PWPI"). Peter S. Park ("Mr. Park"), through one or more affiliated entities, is the controlling manager of the Reporting Person.

Remarks:

As of August 27, 2021, the reporting person is no longer subject to Section 16 in connection with transactions in the securities of the Company and therefore will no longer report any such transactions on Form 4 or Form 5.